Sustainable Funding From a Diverse Donor Base Supports n-Lorem Foundation and its Nano-rare Patients
businesswire.com
news
2022-10-18 00:00:00

October 18, 2022 09:05 AM Eastern Daylight Time SAN DIEGO--(BUSINESS WIRE)--n-Lorem, a nonprofit foundation, announced today that it has surpassed its 2022 fundraising goal of $8 million with more than $17 million in committed cash in 2022. As a non-profit, this support is critically important for n-Lorem's mission to discover and develop personalized experimental antisense oligonucleotide (ASO) medicines for nano-rare patients (1 to 30 patients worldwide) for free, for life.

'On behalf of our patients, we are grateful for the committed support from our partners, our individual donors and granting foundations that have come together with a purpose to provide better futures to nano-rare patients.
